Glactiv



Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 78.5%
Hypertension 6.5%
Diabetes Mellitus 3.2%
Dyslipidaemia 1.6%
Pharyngeal Cancer 1.6%
Atypical Mycobacterial Infection 1.1%
Angina Unstable 0.5%
Asthma 0.5%
Bronchopulmonary Aspergillosis 0.5%
Cerebral Circulatory Failure 0.5%
Cholangiocarcinoma 0.5%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy 0.5%
Dementia Alzheimer's Type 0.5%
Diabetic Neuropathy 0.5%
Gastritis Prophylaxis 0.5%
Hyperlipidaemia 0.5%
Lumbar Spinal Stenosis 0.5%
Non-small Cell Lung Cancer 0.5%
Osteoporosis 0.5%
Parkinson's Disease 0.5%
Hypoglycaemia 18.6%
Interstitial Lung Disease 10.2%
Cerebral Infarction 6.8%
Rhabdomyolysis 6.8%
Autoimmune Pancreatitis 5.1%
Liver Disorder 5.1%
Amylase Increased 3.4%
Drug Eruption 3.4%
Gastric Cancer 3.4%
Hypoglycaemic Unconsciousness 3.4%
Ileus 3.4%
Lung Neoplasm Malignant 3.4%
Pancreatic Carcinoma 3.4%
Pancreatitis 3.4%
Pneumatosis Intestinalis 3.4%
Pneumonia 3.4%
Pyelonephritis 3.4%
Renal Impairment 3.4%
Sepsis 3.4%
Weight Increased 3.4%
Secondary
Type 2 Diabetes Mellitus 28.6%
Diabetes Mellitus 18.6%
Rheumatoid Arthritis 10.0%
Hypertension 8.6%
Hyperglycaemia 4.3%
Pharyngeal Cancer 4.3%
Analgesic Therapy 2.9%
Gastritis 2.9%
Gastrointestinal Disorder 2.9%
Hypercholesterolaemia 2.9%
Angina Pectoris 1.4%
Arterial Occlusive Disease 1.4%
Cardiac Failure Congestive 1.4%
Cerebrovascular Accident Prophylaxis 1.4%
Cervical Myelopathy 1.4%
Constipation 1.4%
Diarrhoea 1.4%
Electrolyte Imbalance 1.4%
Gastritis Prophylaxis 1.4%
Hyperuricaemia 1.4%
Cerebral Infarction 8.7%
Inappropriate Antidiuretic Hormone Secretion 8.7%
Parkinsonian Crisis 8.7%
Arrhythmia 4.3%
Coagulopathy 4.3%
Colon Cancer 4.3%
Glycosylated Haemoglobin Increased 4.3%
Hepatitis E 4.3%
Hypoglycaemia 4.3%
Large Intestine Perforation 4.3%
Liver Disorder 4.3%
Liver Function Test Abnormal 4.3%
Overdose 4.3%
Pancreatitis 4.3%
Pleural Effusion 4.3%
Pyelonephritis 4.3%
Pyrexia 4.3%
Status Asthmaticus 4.3%
Stevens-johnson Syndrome 4.3%
Upper Respiratory Tract Inflammation 4.3%
Concomitant
Diabetes Mellitus 19.1%
Chronic Hepatitis C 18.7%
Product Used For Unknown Indication 14.5%
Hypertension 9.8%
Prophylaxis 8.9%
Rheumatoid Arthritis 4.5%
Type 2 Diabetes Mellitus 4.1%
Hepatitis C 2.8%
Constipation 2.7%
Pain 2.2%
Schizophrenia, Disorganised Type 2.2%
Insomnia 1.6%
Hyperlipidaemia 1.4%
Prostate Cancer 1.3%
Atrial Fibrillation 1.1%
Dementia Alzheimer's Type 1.1%
Device Therapy 1.1%
Hyperuricaemia 1.1%
Thrombosis Prophylaxis 1.1%
Hypercholesterolaemia 1.0%
Rash 11.8%
Retinopathy 10.5%
Renal Impairment 7.9%
Vomiting 7.9%
White Blood Cell Count Decreased 7.9%
Rhabdomyolysis 6.6%
Pancreatitis Acute 5.3%
Cholecystitis 3.9%
Erythema Multiforme 3.9%
Hepatic Function Abnormal 3.9%
Neutrophil Count Decreased 3.9%
Pneumonia 3.9%
Pyrexia 3.9%
Acute Myeloid Leukaemia 2.6%
Bladder Cancer 2.6%
Blood Uric Acid Increased 2.6%
Cerebral Infarction 2.6%
Decreased Appetite 2.6%
Dizziness 2.6%
Erythema 2.6%
Interacting
Fungal Skin Infection 100.0%
Drug Interaction 100.0%